Advanced in Restless Legs Syndrome

Philipp Ellmerer

Innsbruck, AT 
Advanced in Restless Legs Syndrome
Innsbruck, AT 
OverviewLocationsClinical Research

Overview

Philipp Ellmerer practices in Innsbruck, Austria. Mr. Ellmerer is rated as an Advanced expert by MediFind in the treatment of Restless Legs Syndrome. His top areas of expertise are Restless Legs Syndrome, Movement Disorders, Parkinson's Disease, and Torticollis.

His clinical research consists of co-authoring 24 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Restless Legs Syndrome.

Gender
Male

Locations

Innsbruck, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Nabilone for Non-motor Symptoms in Parkinson's Disease: An Open-label Study to Evaluate Long-term Safety and Efficacy
Nabilone for Non-motor Symptoms in Parkinson's Disease: An Open-label Study to Evaluate Long-term Safety and Efficacy
Enrollment Status: Completed
Publish Date: March 02, 2021
Intervention Type: Drug
Study Phase: Phase 3
Nabilone for Non-motor Symptoms in Parkinson's Disease: A Randomized Placebo-controlled, Double-blind, Parallel-group, Enriched Enrolment Randomized Withdrawal Study
Nabilone for Non-motor Symptoms in Parkinson's Disease: A Randomized Placebo-controlled, Double-blind, Parallel-group, Enriched Enrolment Randomized Withdrawal Study
Enrollment Status: Completed
Publish Date: March 02, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

24 Total Publications

Protocol for olfactory training in persisting COVID-19-associated loss of smell (SMELL): a monocentric randomised controlled trial conducted in Innsbruck.
Protocol for olfactory training in persisting COVID-19-associated loss of smell (SMELL): a monocentric randomised controlled trial conducted in Innsbruck.
Journal: BMJ open
Published: May 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ellmerer's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile